MYC and nasopharyngeal carcinoma: When NPC cells were treated with the protein synthesis inhibitor cycloheximide (CHX) (50 μg/mL), the stability of c-Myc protein increased after overexpression of circPVT1 and decreased after knockdown of circPVT1 in NPC cells (Fig. 5E).